VERU INC. Revenues
VERU INC. (VERU) reported Revenues of $4.14 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2024-05-08
- VERU INC. revenues for the quarter ending 2024-03-31 was $4.14M, a 37.21% decline year-over-year.
- VERU INC. revenues for the quarter ending 2023-12-31 was $2.14M, a 14.64% decline year-over-year.
- VERU INC. revenues for the quarter ending 2023-09-30 was $3.86M, a 49.19% increase year-over-year.
- VERU INC. revenues for the quarter ending 2023-06-30 was $3.34M, a 65.20% decline year-over-year.
- VERU INC. revenues for fiscal 2023 was $16.30M, a 58.59% decline from fiscal 2022.
- VERU INC. revenues for fiscal 2022 was $39.35M, a 35.76% decline from fiscal 2021.
- VERU INC. revenues for fiscal 2021 was $61.26M, a 43.83% increase from fiscal 2020.
- VERU INC. revenues for fiscal 2020 was $42.59M, a 33.92% increase from fiscal 2019.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|
| 2024-03-31 | $4.14M 10-Q · filed 2024-05-08 | $6.28M 10-Q · filed 2024-05-08 | $10.14M derived: sum of 3 quarters · filed 2024-05-08 | $13.48M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2023-12-31 | $2.14M 10-Q · filed 2024-04-01 | $6.00M derived: sum of 2 quarters · filed 2024-04-01 | $9.34M derived: sum of 3 quarters · filed 2024-04-01 | $15.93M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2023-09-30 | $3.86M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $7.20M derived: sum of 2 quarters · filed 2024-04-01 | $13.79M derived: sum of 3 quarters · filed 2024-05-08 | $16.30M 10-K/A · filed 2024-04-01 | |
| 2023-06-30 | $3.34M 10-Q/A · filed 2023-11-15 | $9.93M derived: sum of 2 quarters · filed 2024-05-08 | $12.43M 10-Q/A · filed 2023-11-15 | $15.02M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2023-03-31 | $6.59M 10-Q · filed 2024-05-08 | $9.09M 10-Q · filed 2024-05-08 | $11.68M derived: sum of 3 quarters · filed 2024-05-08 | $21.28M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $2.51M 10-Q · filed 2024-04-01 | $5.10M derived: sum of 2 quarters · filed 2024-04-01 | $14.70M derived: sum of 3 quarters · filed 2024-04-01 | $27.73M derived: sum of 4 quarters · filed 2024-04-01 | |
| 2022-09-30 | $2.59M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $12.19M derived: sum of 2 quarters · filed 2024-04-01 | $25.22M derived: sum of 3 quarters · filed 2024-04-01 | $39.35M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $9.60M 10-Q/A · filed 2023-11-15 | $22.63M derived: sum of 2 quarters · filed 2023-11-15 | $36.77M 10-Q/A · filed 2023-11-15 | $52.41M derived: sum of 4 quarters · filed 2023-11-15 | |
| 2022-03-31 | $13.03M 10-Q · filed 2023-05-11 | $27.16M 10-Q · filed 2023-05-11 | $42.81M derived: sum of 3 quarters · filed 2023-05-11 | $60.47M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $14.14M 10-Q · filed 2023-02-09 | $29.78M derived: sum of 2 quarters · filed 2023-02-09 | $47.44M derived: sum of 3 quarters · filed 2023-02-09 | $60.78M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-09-30 | $15.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $33.30M derived: sum of 2 quarters · filed 2022-12-05 | $46.64M derived: sum of 3 quarters · filed 2022-12-05 | $61.26M 10-K · filed 2022-12-05 | |
| 2021-06-30 | $17.66M 10-Q · filed 2022-08-11 | $31.00M derived: sum of 2 quarters · filed 2022-08-11 | $45.61M 10-Q · filed 2022-08-11 | $57.36M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $13.34M 10-Q · filed 2022-05-12 | $27.96M 10-Q · filed 2022-05-12 | $39.71M derived: sum of 3 quarters · filed 2022-05-12 | $50.03M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $14.62M 10-Q · filed 2022-02-09 | $26.37M derived: sum of 2 quarters · filed 2022-02-09 | $36.69M derived: sum of 3 quarters · filed 2022-02-09 | $46.63M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-09-30 | $11.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | $22.07M derived: sum of 2 quarters · filed 2021-12-02 | $32.01M derived: sum of 3 quarters · filed 2021-12-02 | $42.59M 10-K · filed 2021-12-02 | |
| 2020-06-30 | $10.32M 10-Q · filed 2021-08-12 | $20.26M derived: sum of 2 quarters · filed 2021-08-12 | $30.84M 10-Q · filed 2021-08-12 | $39.57M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $9.94M 10-Q · filed 2021-05-12 | $20.52M 10-Q · filed 2021-05-12 | $29.25M derived: sum of 3 quarters · filed 2021-05-12 | $38.98M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | $10.58M 10-Q · filed 2021-02-10 | $19.31M derived: sum of 2 quarters · filed 2021-02-10 | $29.03M derived: sum of 3 quarters · filed 2021-02-10 | $36.01M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-09-30 | $8.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | $18.46M derived: sum of 2 quarters · filed 2020-12-10 | $25.43M derived: sum of 3 quarters · filed 2020-12-10 | $31.80M 10-K · filed 2020-12-10 | |
| 2019-06-30 | $9.73M 10-Q · filed 2020-08-13 | $16.70M derived: sum of 2 quarters · filed 2020-08-13 | $23.07M 10-Q · filed 2020-08-13 | $28.28M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $6.98M 10-Q · filed 2020-05-13 | $13.35M 10-Q · filed 2020-05-13 | $18.55M derived: sum of 3 quarters · filed 2020-05-13 | $24.05M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $6.37M 10-Q · filed 2020-02-12 | $11.58M derived: sum of 2 quarters · filed 2020-02-12 | $17.08M derived: sum of 3 quarters · filed 2020-02-12 | ||
| 2018-09-30 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $10.70M derived: sum of 2 quarters · filed 2019-12-12 | $15.86M 10-K · filed 2019-12-12 | ||
| 2018-06-30 | $5.50M 10-Q · filed 2019-08-08 | $10.66M 10-Q · filed 2019-08-08 | |||
| 2017-09-30 | $13.66M 10-K · filed 2018-12-13 | ||||
| 2014-12-31 | $6.66M 10-Q · filed 2015-02-03 | $12.21M derived: sum of 2 quarters · filed 2015-02-03 | $20.11M derived: sum of 3 quarters · filed 2015-02-03 | $24.46M derived: sum of 4 quarters · filed 2015-02-03 | |
| 2014-09-30 | $5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | $13.46M derived: sum of 2 quarters · filed 2014-12-02 | $17.80M derived: sum of 3 quarters · filed 2014-12-02 | $24.49M 10-K · filed 2014-12-02 | |
| 2014-06-30 | $7.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-31 | $12.25M derived: sum of 2 quarters · filed 2014-07-31 | $18.94M 10-Q · filed 2014-07-31 | $23.73M derived: sum of 4 quarters · filed 2015-02-03 | |
| 2014-03-31 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $11.04M 10-Q · filed 2014-05-01 | $15.82M derived: sum of 3 quarters · filed 2015-02-03 | $23.11M derived: sum of 4 quarters · filed 2015-02-03 | |
| 2013-12-31 | $6.69M 10-Q · filed 2015-02-03 | $11.48M derived: sum of 2 quarters · filed 2015-02-03 | $18.76M derived: sum of 3 quarters · filed 2015-02-03 | $28.24M derived: sum of 4 quarters · filed 2015-02-03 | |
| 2013-09-30 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | $12.07M derived: sum of 2 quarters · filed 2014-12-02 | $21.55M derived: sum of 3 quarters · filed 2014-12-02 | $31.46M 10-K · filed 2014-12-02 | $31.46K 10-K · filed 2013-12-03 |
| 2013-06-30 | $7.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-31 | $16.76M derived: sum of 2 quarters · filed 2014-07-31 | $26.67M 10-Q · filed 2014-07-31 | $36.58M derived: sum of 4 quarters · filed 2014-12-02 | |
| 2013-03-31 | $9.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $19.39M 10-Q · filed 2014-05-01 | $29.30M derived: sum of 3 quarters · filed 2014-12-02 | ||
| 2012-12-31 | $9.91M 10-Q · filed 2014-02-03 | $19.82M derived: sum of 2 quarters · filed 2014-12-02 | |||
| 2012-09-30 | $9.91M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | $35.03M 10-K · filed 2014-12-02 | $35.03K 10-K · filed 2013-12-03 | ||
| 2012-06-30 | $25.12M 10-Q · filed 2013-08-01 | ||||
| 2011-09-30 | $18.57K 10-K · filed 2013-12-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |